CD161+ cells are markers of human memory Th17 cells, a cell subset that exhibits inflammatory activity and represents a major target of MS therapy; Th17 cells are abundant in peripheral blood, CSF, and brain lesions in MS patients, and their inflammatory mediators are increased during disease relapse (41). This evidence concerns the gene KLRB1 and myeloid sarcoma.